Cargando…

Effectiveness and safety of oral HIV preexposure prophylaxis for all populations

OBJECTIVE: Preexposure prophylaxis (PrEP) offers a promising new approach to HIV prevention. This systematic review and meta-analysis evaluated the evidence for use of oral PrEP containing tenofovir disoproxil fumarate as an additional HIV prevention strategy in populations at substantial risk for H...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fonner, Virginia A., Dalglish, Sarah L., Kennedy, Caitlin E., Baggaley, Rachel, O’Reilly, Kevin R., Koechlin, Florence M., Rodolph, Michelle, Hodges-Mameletzis, Ioannis, Grant, Robert M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2016
Materias:	Epidemiology and Social
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4949005/ https://www.ncbi.nlm.nih.gov/pubmed/27149090 http://dx.doi.org/10.1097/QAD.0000000000001145

Ejemplares similares

Values and Preferences on the Use of Oral Pre-exposure Prophylaxis (PrEP) for HIV Prevention Among Multiple Populations: A Systematic Review of the Literature
por: Koechlin, Florence M., et al.
Publicado: (2016)

Safety and efficacy of long-acting injectable cabotegravir as preexposure prophylaxis to prevent HIV acquisition
por: Fonner, Virginia A., et al.
Publicado: (2023)

Oral preexposure prophylaxis continuation, measurement and reporting
por: Stankevitz, Kayla, et al.
Publicado: (2020)

Improving HIV test uptake and case finding with assisted partner notification services
por: Dalal, Shona, et al.
Publicado: (2017)

The effect of oral preexposure prophylaxis on the progression of HIV-1 seroconversion
por: Donnell, Deborah, et al.
Publicado: (2017)

Incidence of sexually transmitted infections before and after preexposure prophylaxis for HIV
por: Nguyen, Vinh-Kim, et al.
Publicado: (2018)

In what circumstances could nondaily preexposure prophylaxis for HIV substantially reduce program costs?
por: Mitchell, Kate M., et al.
Publicado: (2018)

Population-level effectiveness of a national HIV preexposure prophylaxis programme in MSM
por: Estcourt, Claudia, et al.
Publicado: (2021)

Elimination prospects of the Dutch HIV epidemic among men who have sex with men in the era of preexposure prophylaxis
por: Rozhnova, Ganna, et al.
Publicado: (2018)

Preexposure prophylaxis strategies for African–American women affected by mass incarceration
por: Adams, Joëlla W., et al.
Publicado: (2021)

Characterization of dolutegravir drug resistance in persons diagnosed with HIV after exposure to long-acting injectable cabotegravir for preexposure prophylaxis
por: Ahluwalia, Amrit Kaur, et al.
Publicado: (2022)

Global Epidemiologic Characteristics of Sexually Transmitted Infections Among Individuals Using Preexposure Prophylaxis for the Prevention of HIV Infection: A Systematic Review and Meta-analysis
por: Ong, Jason J., et al.
Publicado: (2019)

A Mobile Health Strategy to Support Adherence to Antiretroviral Preexposure Prophylaxis
por: Fuchs, Jonathan D., et al.
Publicado: (2018)

Optimizing Delivery of HIV Preexposure Prophylaxis for Women in the United States
por: Aaron, Erika, et al.
Publicado: (2018)

The European preexposure prophylaxis revolution
por: Cairns, Gus, et al.
Publicado: (2016)

Beyond the 90-90-90: refocusing HIV prevention as part of the global HIV response
por: Baggaley, Rachel, et al.
Publicado: (2016)

Transient Changes in Preexposure Prophylaxis Use and Daily Sexual Behavior After the Implementation of COVID-19 Restrictions Among Men Who Have Sex With Men
por: Jongen, Vita W., et al.
Publicado: (2021)

Eligibility for HIV Preexposure Prophylaxis, Intention to Use Preexposure Prophylaxis, and Informal Use of Preexposure Prophylaxis Among Men Who Have Sex With Men in Amsterdam, the Netherlands
por: Hulstein, Sebastiaan H., et al.
Publicado: (2021)

The use of preexposure treatments for HIV prophylaxis
por: Majid, Adrian, et al.
Publicado: (2012)

Statistical issues in trials of preexposure prophylaxis
por: Dunn, David T., et al.
Publicado: (2016)

Estimating HIV pre-exposure prophylaxis need and impact in Malawi, Mozambique and Zambia: A geospatial and risk-based analysis
por: Stelzle, Dominik, et al.
Publicado: (2021)

Weighing the Risk of Drug Resistance With the Benefits of HIV Preexposure Prophylaxis
por: Grant, Robert M., et al.
Publicado: (2015)

Feasibility, Acceptability, and Adherence with Short-Term HIV Preexposure Prophylaxis in Female Sexual Partners of Migrant Miners in Mozambique
por: Lahuerta, Maria, et al.
Publicado: (2017)

Pharmacologic Considerations for Preexposure Prophylaxis in Transgender Women
por: Anderson, Peter L., et al.
Publicado: (2016)

Integrating pre-exposure prophylaxis of HIV infection into family planning services: a scoping review
por: Gotsche, Caroline I, et al.
Publicado: (2023)

Economic compensation interventions to increase uptake of voluntary medical male circumcision for HIV prevention: A systematic review and meta-analysis
por: Kennedy, Caitlin E., et al.
Publicado: (2020)

Service delivery interventions to increase uptake of voluntary medical male circumcision for HIV prevention: A systematic review
por: Atkins, Kaitlyn, et al.
Publicado: (2020)

Interventions to improve daily medication use among adolescents and young adults: what can we learn for youth pre-exposure prophylaxis services?
por: Velloza, Jennifer, et al.
Publicado: (2021)

P41 - Preexposure prophylaxis of infants’ food allergy
por: Denisova, Svetlana, et al.
Publicado: (2014)

Understanding the pathways leading to socioeconomic inequalities in HIV testing uptake in 18 sub-Saharan African countries
por: Ante-Testard, Pearl Anne, et al.
Publicado: (2022)

Family planning counseling for women living with HIV: a systematic review of the evidence of effectiveness on contraceptive uptake and pregnancy incidence, 1990 to 2011
por: O’Reilly, Kevin R, et al.
Publicado: (2013)

Reaching people with undiagnosed HIV infection through assisted partner notification
por: Dalal, Shona, et al.
Publicado: (2017)

Effect of 6-Month HIV Preexposure Prophylaxis Dispensing With Interim Self-testing on Preexposure Prophylaxis Continuation at 12 Months: A Randomized Noninferiority Trial
por: Ortblad, Katrina F., et al.
Publicado: (2023)

Adherence to Preexposure Prophylaxis: Current, Emerging, and Anticipated Bases of Evidence
por: Amico, K. Rivet, et al.
Publicado: (2014)

Preexposure Prophylaxis for the Prevention of HIV Infection — 2014 Available Online
Publicado: (2014)

HIV Preexposure Prophylaxis in the U.S. Military Services — 2014–2016
por: Blaylock, Jason M., et al.
Publicado: (2018)

Sharing experience: Hydroxychloroquine in preexposure prophylaxis against COVID-19
por: Kulkarni, Chanda, et al.
Publicado: (2021)

Clinical Considerations in the Selection of Preexposure Prophylaxis for HIV Prevention in Canada
por: Knox, David C., et al.
Publicado: (2022)

Mathematical modelling of the influence of serosorting on the population-level HIV transmission impact of pre-exposure prophylaxis
por: Wang, Linwei, et al.
Publicado: (2021)

HIV-1 Drug Resistance in the iPrEx Preexposure Prophylaxis Trial
por: Liegler, Teri, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_inpsbhvqmhrgt0f1uchr8ie3jf